Suboxone is not considered dangerous to the liver for most people who take it. In a head-to-head clinical trial comparing Suboxone to methadone over six months, researchers found no evidence of liver damage in either group, and the study’s authors concluded that physicians can prescribe either medication without major concern for liver injury. That said, Suboxone is processed heavily by the liver, and a small percentage of users do show elevated liver enzymes, so the context matters.
How Suboxone Affects the Liver
Suboxone contains two active ingredients: buprenorphine (a partial opioid) and naloxone (an opioid blocker). When you take a sublingual film or tablet, the medication passes through your liver before reaching the rest of your body. This is called first-pass metabolism, and it means your liver does significant work every time you take a dose. The liver breaks down buprenorphine using a specific enzyme system (CYP 3A4), which is the same pathway responsible for processing many other common medications.
Because the liver handles so much of the processing, any pre-existing liver condition can change how the drug behaves in your body. People with mild liver impairment generally don’t need a dose adjustment. But for people with moderate liver problems, the FDA notes that Suboxone may not be appropriate for starting treatment, though it can sometimes be continued cautiously for maintenance. For severe liver impairment, Suboxone is not recommended at all.
How Common Is Liver Injury?
Clinically significant liver enzyme elevations from Suboxone are uncommon. In the randomized trial comparing buprenorphine/naloxone to methadone, only about 2.1% of the buprenorphine group showed extreme elevations in liver tests at any point during six months of treatment. The methadone group was slightly higher at 3.6%, though the difference wasn’t statistically significant. These numbers are reassuring: the vast majority of patients showed no concerning liver changes.
The FDA does include a warning in Suboxone’s prescribing information about the risk of hepatitis and hepatic events, but notably, there is no boxed warning (the most serious type of FDA warning) related to liver damage. The labeling recommends baseline liver function tests before starting Suboxone and periodic monitoring during treatment, which is standard practice for many medications processed by the liver.
The Hepatitis C Factor
Liver safety gets more complicated for people with hepatitis C, which is common among people with opioid use disorder. In a study of adolescents and young adults, hepatitis C was far more strongly associated with elevated liver enzymes than buprenorphine itself. About 19% of participants had hepatitis C at baseline, and the virus, not the medication, was the primary driver of abnormal liver tests.
Here’s what’s especially interesting: participants who stayed on buprenorphine for 12 weeks actually had lower rates of liver enzyme elevation related to hepatitis C than those who went through short-term detoxification. The likely explanation isn’t that buprenorphine protects the liver directly. Instead, people on stable buprenorphine treatment used significantly less heroin, cocaine, marijuana, and injection drugs, all of which can stress the liver. In other words, the medication’s benefit of reducing illicit drug use may indirectly protect your liver more than it harms it.
Suboxone vs. Methadone for Liver Safety
If you’re weighing your treatment options, the liver safety profiles of Suboxone and methadone are essentially equivalent. The randomized trial found no significant differences between the two medications in changes to liver enzyme levels over six months. Extreme liver test elevations were slightly more common in the methadone group (3.6% vs. 2.1%), but this difference was not statistically meaningful. Neither medication caused notable liver damage in the study population overall.
Signs of Liver Stress to Watch For
While serious liver problems from Suboxone are rare, it’s worth knowing what to look for. Symptoms of drug-induced liver stress include yellowing of the skin or eyes (jaundice), unusually dark urine, pale or clay-colored stools, persistent nausea or vomiting, unexplained fatigue, and pain or tenderness in the upper right side of your abdomen. These symptoms can develop gradually, so they’re easy to dismiss as something else.
Routine blood work is the most reliable way to catch liver enzyme elevations early, before symptoms appear. Your prescriber will typically check your liver function before you start Suboxone and at intervals during treatment. If your levels rise, adjusting the dose or exploring alternatives is usually straightforward, and elevated enzymes often return to normal once the cause is addressed.
The Bigger Picture
The question of whether Suboxone is “bad” for your liver deserves context. Untreated opioid use disorder carries its own serious liver risks: hepatitis B and C from shared needles, liver damage from contaminants in street drugs, heavy alcohol use that often accompanies addiction, and acetaminophen toxicity from combination painkillers. For the overwhelming majority of people, the small and manageable liver risk from Suboxone is far outweighed by the protection that comes from stable treatment and reduced illicit drug use. The medication isn’t liver-toxic in the way that, say, chronic heavy drinking is. It simply requires the same kind of routine monitoring that many long-term medications do.